---
document_datetime: 2023-09-21 18:45:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cystagon-epar-all-authorised-presentations_en.pdf
document_name: cystagon-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8561642
conversion_datetime: 2025-12-15 22:17:10.915345
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical form   | Route of administration   | Packaging     |   Package size |
|-----------------|-----------------|------------|-----------------------|---------------------------|---------------|----------------|
| EU/1/97/039/001 | Cystagon        | 50 mg      | Hard capsule          | Oral use                  | Bottle (HDPE) |            100 |
| EU/1/97/039/002 | Cystagon        | 50 mg      | Hard capsule          | Oral use                  | Bottle (HDPE) |            500 |
| EU/1/97/039/003 | Cystagon        | 150 mg     | Hard capsule          | Oral use                  | Bottle (HDPE) |            100 |
| EU/1/97/039/004 | Cystagon        | 150 mg     | Hard capsule          | Oral use                  | Bottle (HDPE) |            500 |